Read the First Edition of The Lens, a new magazine by LSI arrow-icon

Travis Bond, Altoida - Studio Interview | LSI Europe ‘22

Altoida is using technology to predict the onset of neurlogical diseases, such as Alzheimer's disease, before symptoms occur. The company's platform evaluates an individual's risk by interrogating 800 digital biomarkers collected through a digital assessment and augmented reality (AR).
Speakers
Travis Bond
Travis Bond
CEO, Altoida

LSI USA ‘25 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

March 17-21, 2025 Waldorf Astoria, Monarch Beach | Dana Point, CA Register arrow